1. Home
  2. Analysis
  3. Methyldopa
  4. Blindness

Methyldopa and Blindness - a phase IV clinical study of FDA data

Summary:

Blindness is reported as a side effect among people who take Methyldopa (methyldopa), especially for people who are female, 30-39 old, also take Lexapro, and have Depression.

The phase IV clinical study analyzes which people have Blindness when taking Methyldopa. It is created by eHealthMe based on reports of 6,345 people who have side effects when taking Methyldopa from the FDA, and is updated regularly.

What is Methyldopa?

Methyldopa has active ingredients of methyldopa. It is often used in high blood pressure. eHealthMe is studying from 6,475 Methyldopa users. Check the latest studies of Methyldopa.

What is Blindness?

Blindness is found to be associated with 1,509 drugs and 1,986 conditions by eHealthMe. Check the latest studies of Blindness.

On Jul, 11, 2026

6,345 people reported to have side effects when taking Methyldopa.
Among them, 12 people (0.19%) have Blindness.

Could Methyldopa cause Blindness?

Among these 12 people:

What is the gender of people who have Blindness when taking Methyldopa? *

  • female: 81.82 %
  • male: 18.18 %

What is the age of people who have Blindness when taking Methyldopa? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 10 %
  • 20-29: 10 %
  • 30-39: 40 %
  • 40-49: 0.0 %
  • 50-59: 10 %
  • 60+: 30 %

What are other drugs people take besides Methyldopa? *

  1. Lexapro: 5 people, 41.67%
  2. Lipitor: 4 people, 33.33%
  3. Glucotrol Xl: 4 people, 33.33%
  4. Abilify: 4 people, 33.33%
  5. Seroquel: 4 people, 33.33%
  6. Furosemide: 3 people, 25.00%
  7. Enalapril Maleate: 2 people, 16.67%
  8. Norvasc: 2 people, 16.67%
  9. Nifedipine: 2 people, 16.67%
  10. Retrovir: 1 person, 8.33%

What are other side effects people have besides Blindness? *

  1. Diabetes: 4 people, 33.33%
  2. Diabetic Nephropathy (diabetic kidney disease): 4 people, 33.33%
  3. Eye Disorder: 4 people, 33.33%
  4. Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 25.00%
  5. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 3 people, 25.00%
  6. Rashes (redness): 2 people, 16.67%
  7. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 16.67%
  8. Blood Disorder: 2 people, 16.67%
  9. Cataract (clouding of the lens inside the eye): 2 people, 16.67%
  10. Diarrhea: 2 people, 16.67%

What are the existing conditions these people have? *

  1. Depression: 5 people, 41.67%
  2. Bipolar Disorder (mood disorder): 4 people, 33.33%
  3. Type 2 Diabetes: 1 person, 8.33%
  4. Metastases To Breast (cancer spreads to brain): 1 person, 8.33%
  5. Metastases To Bone (cancer spreads to bone): 1 person, 8.33%
  6. Local Anaesthesia: 1 person, 8.33%
  7. High Blood Cholesterol: 1 person, 8.33%
  8. Diabetes: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Methyldopa and have Blindness?

- Check whether Blindness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methyldopa:

Blindness treatments and more:

How severe was Blindness and when was it recovered:

Expand to all the drugs that have ingredients of methyldopa:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methyldopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blindness:

Browse all the conditions that are associated with Blindness:

How the study uses the data?

The study uses data from the FDA. It is based on methyldopa (the active ingredients of Methyldopa) and Methyldopa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.